Matica Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- Matica Biotechnology's estimated annual revenue is currently $14.9M per year.
- Matica Biotechnology's estimated revenue per employee is $155,000
Employee Data
- Matica Biotechnology has 96 Employees.
- Matica Biotechnology grew their employee count by -6% last year.
Matica Biotechnology's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Operations Officer | Reveal Email/Phone |
4 | Chief Commercial Officer | Reveal Email/Phone |
5 | VP Corporate Strategy | Reveal Email/Phone |
6 | VP / Global Head Business Development | Reveal Email/Phone |
7 | VP Alliance Management | Reveal Email/Phone |
8 | EVP Commercial Operations | Reveal Email/Phone |
9 | Director Supply Chain | Reveal Email/Phone |
10 | Senior Director Operations | Reveal Email/Phone |
Matica Biotechnology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is Matica Biotechnology?
Matica Biotechnology, Inc. is a contract development and manufacturing organization (CDMO) specializing in the production of virus-based cell & gene therapies, vaccines, and other precision medicines for our clients. Our GMP facility is currently under construction in College Station, TX, slated to open in Q3 2021. While our facility may be new, we have assembled an exceptional staff of industry veterans, most with 10-15 years of experience in the production of virus and advanced therapies for some of the most innovative products on market and in the clinic today. With the support of our parent company CHA Biotech, our goal is to establish a streamlined, global manufacturing solution for your viral vector product. Our single-use bioreactor platforms, remote monitoring systems, quality driven processes and dedicated staff come together to create an exceptional framework to ensure the product development and manufacturing process keeps pace with the often-accelerated clinical approval pathways to the patient bedside. Contact us today at info@maticabio.com or visit www.maticabio.com to learn more!
keywords:N/AN/A
Total Funding
96
Number of Employees
$14.9M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 97 | 29% | N/A |
#2 | $14.7M | 98 | 0% | N/A |
#3 | $25.1M | 99 | 13% | N/A |
#4 | $14.9M | 103 | 24% | N/A |
#5 | $15.2M | 105 | N/A | N/A |